REFRACTORY ANEMIA

Clinical trials for REFRACTORY ANEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ANEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 2

New drug combo shows promise for blood cancers in early trial

Disease control Ongoing

This study tested a combination of two drugs, vorinostat and azacitidine, in 135 people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The goal was to find the safest dose and see how well the drugs work together to stop cancer cell growth. Participants rece…

Matched conditions: REFRACTORY ANEMIA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 08, 2026 12:03 UTC

REFRACTORY ANEMIA

Get alerted when new REFRACTORY ANEMIA trials appear

New drug combo shows promise for blood cancers in early trial